Table 3.
Characteristics of patients included in the CINV analysis.
| Characteristic | All patients (n = 36) |
|---|---|
| Median age, years (IQR) | 59 (52–65) |
| Sex, male | 20 (56, 40–70) |
| Performance status | |
| 0 | 33 (92, 78–97) |
| 1 | 2 (6, 2–18) |
| 2 | 1 (3, 0.5–14) |
| Chemotherapy regimen | |
| FOLFOX | 10 (28, 16–44) |
| CAPOX | 26 (72, 56–84) |
| Use of molecular target drug | |
| Yes | 12 (33, 20–50) |
| Colorectal resection | |
| Yes | 30 (83, 68–92) |
| Stoma | |
| Ileostomy | 4 (11, 4–25) |
| Colostomy | 3 (8, 3–22) |
| Purpose of chemotherapy | |
| Neoadjuvant treatment | 2 (6, 2–18) |
| Adjuvant treatment | 18 (50, 34–66) |
| Metastatic disease | 16 (44, 30–60) |
| Smoking history | |
| Never | 17 (47, 32–63) |
| Ex-smoker | 19 (53, 37–68) |
| Alcohol use | |
| Light/non-drinker | 28 (78, 62–88) |
| Drinker | 8 (22, 12–38) |
| History of vomiting during pregnancy | 8 (50, 28–72) |
| History of motion sickness | 5 (14, 6–29) |
IQR interquartile range.
Data are given as n (%, confidence interval) unless otherwise noted.